Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

Recent publications published by researchers at the MRC WIMM.

Single-cell immune multi-omics and repertoire analyses in pancreatic ductal adenocarcinoma reveal differential immunosuppressive mechanisms within different tumour microenvironments

Preprint

Sivakumar S. et al, (2023)

Clinical, neurophysiological and serological clues for the diagnosis of neuromyotonia and distinction from cramp-fasciculation syndrome.

Journal article

Spagni G. et al, (2023), Neuromuscul Disord

Abstract 668: The translational biology of small molecule GPR65 inhibitors: shared effects between mouse models and human primary tumors highlight the unique transformative potential of targeting a genetically validated innate immune checkpoint

Journal article

Cipriani B. et al, (2023), Cancer Research, 83, 668 - 668

Deep sequencing of the T cell Receptor reveals common and reproducible CD8+signatures of response to checkpoint immunotherapy

Preprint

Watson RA. et al, (2023)

Ibex: Variational autoencoder for single-cell BCR sequencing

Preprint

Borcherding N. et al, (2022)

Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.

Journal article

Spagni G. et al, (2022), J Neurol Neurosurg Psychiatry

Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19.

Journal article

Kotanidis CP. et al, (2022), Lancet Digit Health

Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders.

Journal article

Damato V. et al, (2022), Proc Natl Acad Sci U S A, 119

Dissecting the autoantibody repertoire in CASPR2-antibody encephalitis

Journal article

Sun B. et al, (2022), Journal of Neurology, Neurosurgery & Psychiatry, 93, A4.1 - A4

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.

Journal article

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58

An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.

Journal article

Peng Y. et al, (2022), Nat Immunol, 23, 50 - 61

Double-jeopardy: scRNA-seq doublet/multiplet detection using multi-omic profiling.

Journal article

Sun B. et al, (2021), Cell Rep Methods, 1

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Working paper

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None. et al, (2021)

Double-Jeopardy: scRNA-seq Doublet/Multiplet Detection Using Multi-Omic Profiling

Journal article

Sun B. et al, (2020), SSRN Electronic Journal

The B cell immunobiology that underlies CNS autoantibody-mediated diseases.

Journal article

Sun B. et al, (2020), Nat Rev Neurol, 16, 481 - 492

Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.

Journal article

Ramberger M. et al, (2020), Brain, 143, 1731 - 1745

Immunological mechanisms for the efficacy of Rituximab in aquaporin-4 autoantibody mediated Neuromyelitis Optica spectrum disorders

Other

Damato V. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 74 - 74

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort.

Journal article

Cross H. et al, (2020), Front Neurol, 11

Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes

Journal article

Waters P. et al, (2020), JAMA NEUROLOGY, 77, 82 - 93

Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.

Journal article

Waters P. et al, (2020), JAMA Neurol, 77, 82 - 93

Load More